John G. Houston Ph.D.
Net Worth

Last updated:

What is John G. Houston Ph.D. net worth?

The estimated net worth of Dr. John G. Houston Ph.D. is at least $29,573,799 as of 23 Feb 2024. He owns shares worth $7,401,902 as insider, has earned $15,031,897 from insider trading and has received compensation worth at least $7,140,000 in Arvinas, Inc..

What is the salary of John G. Houston Ph.D.?

Dr. John G. Houston Ph.D. salary is $1,020,000 per year as Chief Executive Officer, Pres & Director in Arvinas, Inc..

How old is John G. Houston Ph.D.?

Dr. John G. Houston Ph.D. is 65 years old, born in 1960.

What stocks does John G. Houston Ph.D. currently own?

As insider, Dr. John G. Houston Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Arvinas, Inc. (ARVN) Chief Executive Officer, Pres & Director 1,036,681 $7.14 $7,401,902

What does Arvinas, Inc. do?

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.

ARVN logo
ARVN
Arvinas, Inc.
$7.14

John G. Houston Ph.D. insider trading

Arvinas, Inc.

Dr. John G. Houston Ph.D. has made 10 insider trades between 2018-2024, according to the Form 4 filled with the SEC. Most recently he sold 5,196 units of ARVN stock worth $244,472 on 23 Feb 2024.

The largest trade he's ever made was exercising 45,922 units of ARVN stock on 2 Aug 2021. As of 23 Feb 2024 he still owns at least 1,036,681 units of ARVN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 5,196 $47.05 $244,472
Option
Restricted Stock Units 17,510 N/A N/A
Option
Common Stock 17,510 N/A N/A
Sale
Common Stock 5,878 $29.53 $173,577
Option
Common Stock 17,511 N/A N/A
Option
Restricted Stock Units 17,511 N/A N/A
Sale
Common Stock 6,024 $63.94 $385,175
Sale
Common Stock 40,000 $87.99 $3,519,640
Option
Stock Option (right to buy) 40,000 $16 $640,000
Option
Common Stock 40,000 $16 $640,000
Option
Stock Option (right to buy) 4,690 $16 $75,040
Option
Common Stock 4,690 $16 $75,040
Option
Common Stock 45,922 $16 $734,752
Option
Stock Option (right to buy) 45,922 $16 $734,752
Sale
Common Stock 45,922 $98.82 $4,538,012
Option
Stock Option (right to buy) 43,886 $16 $702,176
Option
Common Stock 43,886 $16 $702,176
Sale
Common Stock 43,886 $81.58 $3,580,044
Option
Stock Option (right to buy) 700 $16 $11,200
Sale
Common Stock 700 $16 $11,200
Option
Common Stock 700 $16 $11,200
Option
Common Stock 17,510 N/A N/A
Option
Restricted Stock Units 17,510 N/A N/A
Sale
Common Stock 8,115 $77.45 $628,507
Option
Stock Option (right to buy) 45,560 $8 $364,480
Option
Common Stock 45,560 $16 $728,960
Option
Common Stock 45,560 N/A N/A
Option
Stock Option (right to buy) 45,560 $16 $728,960
Sale
Common Stock 44,000 $39.73 $1,747,988
Option
Stock Option (right to buy) 6,250 $16 $100,000
Option
Common Stock 6,250 $16 $100,000
Sale
Common Stock 5,405 $37.61 $203,282
Option
Restricted Stock Units 17,511 N/A N/A
Option
Common Stock 17,511 N/A N/A
Option
Stock Option (right to buy) 12,500 $16 $200,000
Option
Common Stock 12,500 $16 $200,000
Purchase
Common Stock 30,000 $16 $480,000

Arvinas key executives

Arvinas, Inc. executives and other stock owners filed with the SEC: